Labrosse Nicole

EDGAR CIK 0001910662

Halozyme Therapeutics, Inc. - HALO

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
CFO
SVP, CHIEF FINANCIAL OFFICER
Direct Buys
0
$0
0 Shares
Direct Sells
1
($173,584)
-2,227 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
09/22/2025
10b5-1
09/23/2025
Sell
-2,227 @ $77.95
 ($173,584) 22,079 (-9.16%) Direct